These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 16423995)
21. The role of X-linked genes in breast cancer. Thakur A; Xu H; Wang Y; Bollig A; Biliran H; Liao JD Breast Cancer Res Treat; 2005 Sep; 93(2):135-43. PubMed ID: 16187233 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of c-myc proto-oncogene in primary human breast carcinomas. Pavelic ZP; Steele P; Preisler HD Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688 [TBL] [Abstract][Full Text] [Related]
23. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells. Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787 [TBL] [Abstract][Full Text] [Related]
25. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression. Zhang Y; Sif S; DeWille J J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507 [TBL] [Abstract][Full Text] [Related]
26. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer. Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161 [TBL] [Abstract][Full Text] [Related]
27. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068 [TBL] [Abstract][Full Text] [Related]
28. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120 [TBL] [Abstract][Full Text] [Related]
29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
30. [MiR-122 regulates the expression of PEG10 in hepatoma cell lines]. Chang Y; He XX; Li PY; Lin JS Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):288-91. PubMed ID: 20460050 [TBL] [Abstract][Full Text] [Related]
31. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization]. Yang S; Wang M; You W Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990 [TBL] [Abstract][Full Text] [Related]
32. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Ray RB; Steele R; Seftor E; Hendrix M Cancer Res; 1995 Sep; 55(17):3747-51. PubMed ID: 7641187 [TBL] [Abstract][Full Text] [Related]
33. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras. Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049 [TBL] [Abstract][Full Text] [Related]
34. [Establishment of PEG10 transgenic mouse and effects of PEG10 on growth, metastasis of transplanted tumor in mice]. Liu Y; Lin JS; Zheng XM; Tan JQ; Wang ZJ; Zhang Q; Wu W; Chang Y Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):455-8. PubMed ID: 19567027 [TBL] [Abstract][Full Text] [Related]
35. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. Cosgrave N; Hill AD; Young LS J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079 [TBL] [Abstract][Full Text] [Related]
36. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in]. Yao DS; Li L; Garson K; Vanderhyden BC Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735 [TBL] [Abstract][Full Text] [Related]
37. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y; San-Marina S; Yang L; Khoury H; Minden MD Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147 [TBL] [Abstract][Full Text] [Related]
38. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation. Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma. Wu B; Wang M; You W; Yang S Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322 [TBL] [Abstract][Full Text] [Related]
40. A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice. Chatterji B; Borlak J Proteomics; 2009 Feb; 9(4):1044-56. PubMed ID: 19180532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]